Safety and Efficacy of Clobazam in Subjects With Lennox-Gastaut Syndrome.

Trial Profile

Safety and Efficacy of Clobazam in Subjects With Lennox-Gastaut Syndrome.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Aug 2014

At a glance

  • Drugs Clobazam (Primary)
  • Indications Lennox-Gastaut syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Sep 2009 Actual end date changed from Aug 2006 to Oct 2006 as reported by ClinicalTrials.gov.
    • 20 May 2009 Lundbeck A/S added as trial sponsor/affiliate as reported by ClinicalTrials.gov.
    • 30 Nov 2007 Results have been presented at EIS 2007 (1088706)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top